We have investigated the distribution of immunoreactive endothelins (irET) in fetal fluids and expression of ET precursor genes in villous tissue during the first trimester. Samples of maternal plasma (n ⍧ 6), coelomic fluid (n ⍧ 28), amniotic fluid (n ⍧ 23) and villous tissue (n ⍧ 3) were obtained from 30 pregnancies immediately before surgical termination at 7-12 weeks gestation. irET concentration was measured in plasma and fluids using two different radioimmunoassay kits, i.e. RPA 545 and RPA 555 and high performance liquid chromatography (HPLC). Total RNA was extracted and purified from villous tissue, reverse transcription and polymerase chain reaction (RT-PCR) were performed to evaluate the expression of ET-related genes. The irET concentration as evaluated by both kits was significantly higher (P < 0.005) in maternal plasma than in coelomic or amniotic fluid and significantly higher (P < 0.005) in coelomic fluid than in amniotic fluid using the RPA 555 kit. The profile of ET obtained by the HPLC-radioimmunoassay (RPA 555 kit) method confirmed significantly (P < 0.005) higher ET concentration in coelomic than in amniotic fluid, although a similar distribution pattern for the three ET was observed in both embryonic fliud cavities. ET-3 was the predominant isoform in both fluids, reaching 19.4 ⍨ 2.0 pg/ml and 6.3 ⍨ 1.6 pg/ml in coelomic and amniotic fluid, respectively. Coelomic or amniotic fluid irET concentration did not change with gestational age irrespective of the kit used. RT-PCR demonstrated that first trimester placenta expresses the genes encoding for prepro-ET-1, -ET-2 and -ET-3. The similar ET distribution pattern in both fluid cavities could reflect their origin from the villous tissue and suggests that ET may play a role in the development of placenta and other fetal organs during organogenesis.
Introduction
. These precursor proteins are post-translationally processed into biologically inactive intermediate forms (bigET) Endothelins (ET) are small peptides which were originally and finally into mature peptides. ET concentrations have isolated from aortic endothelial cells (Yanagisawa and Masaki, previously been measured in maternal plasma, fetal plasma 1989; Anggard et al., 1990; Ghandi et al., 1994) . ET are the and amniotic fluid of second and third trimester pregnancies, most potent endogenous vasoconstrictor peptides known to using radioimmunoassays or immunoenzymatic assays. Howdate and vascular smooth muscle cells of most human tissues ever, the use of different extraction procedures and antisera contain specific binding sites for endothelin. ET binding sites can explain important discrepancies previously found in the have also been found in non-vascular smooth muscle and in ET immunoreactivity rates (Ferré, 1995) . Recent experiments, most peripheral organs including the uterine myometrium and using different radioimmunoassays, with and without crossthe villous trophoblast (Mondon et al., 1993; Graf et al., 1996) reactivity for ET-1 and ET-3, have shown that immunowhere they are also thought to have a role as a growth factor reactive ET (irET) concentrations increase in the last month and mitogenic agents (Kilpatrick et al., 1993) . The presence of pregnancy compared to mid pregnancy in both maternal of ET mRNA and binding sites in the brain suggests that these plasma and amniotic fluid (Carbonne et al., 1998) . peptides may also have a role as a neurotransmitter or
The third month of human pregnancy is a stage of considerneuromodulator (Yoshizawa et al., 1990) . Although ET have able transformation in the anatomy of the fetal environment. a short half-life of~1 min, and are therefore considered During that period, the secondary yolk sac, which is the site as locally active peptides rather than systemic hormones, of the first extra-embryonic human circulation, degenerates, variations in ET in maternal serum and amniotic fluid the exocoelomic cavity closes progressively under the pressure concentrations throughout pregnancy suggest a possible role of the growing amniotic cavity, two-thirds of the primitive in feto-placental development and parturition (Ferré, 1995) . placenta are transformed into the chorion laeve and a continuThree separate human ET-related genes have been identified ous intervillous circulation is fully established (Jones and Jauniaux, 1995) . The aim of the present study is to evaluate encoding for prepro-ET-1, ET-2 and ET-3 respectively (Inoue the possible role of endothelin during this early phase of pregnancy development by examining the distribution of irET in fetal fluids using two different radioimmunoassays and high-performance liquid chromatography (HPLC)-radioimmunoassay and by evaluating the expression of ET precursor genes in villous tissue during the first trimester.
Materials and methods

Samples
Coelomic and amniotic fluids, maternal peripheral venous blood and placental tissue were obtained from 30 women at 7-12 weeks gestation immediately before termination of pregnancy for psychological reasons. None of the mothers had evidence of vaginal infection. Gestational age was determined from the date of the last menstrual period and confirmed by ultrasound measurement of the crown-rump length. Only pregnancies which had been uncomplicated and with a fetal heart rate within normal range were incorporated in the study. Cervical priming was not performed before the surgical procedure.
After written informed consent, coelomic and amniotic fluid samples of 1.0 ml minimum were aspirated from the corresponding cavities, as previously described (Jauniaux et al., 1993) . In brief, coelomic fluid (n ϭ 28) was first aspirated using a 20-gauge needle. Retention times of standard peptides are shown by arrows. See All biological fluids were collected in tubes containing 10 mg Table II for further data. EDTA. Plasma was immediately separated from blood cells by centrifugation (900 g for 20 min at 4°C) and stored at -80°C before assay. Small pieces of placental tissues were also collected from three portion, whereas in the RPA 555 kit, the antiserum recognized the pregnancies at 7, 7 and 8 weeks gestation respectively. The placental C-terminal portion. The cross-reactivity for ET-1, ET-2, ET-3 and villi were washed several times with phosphate-buffered saline, bigET-1 was 100, 144, 52 and 0.4% respectively. ET-1 was used as pH 7.4, to remove blood. Small tissue fragments free of fetal the standard in both radioimmunoassays. The sensitivity, defined as membranes were teased apart to provide explants which gave the the amount of ET-1 needed to reduce zero dose binding by 2 SD, characteristic tree-like appearance of placental villi. The villi were was 0.5 pg/tube. For a 100 µl sample from a 1 ml extract, the lower immediately plunged in Trizol reagent (Life Technologies, Paris, limit of detection was 1.2 pg/ml. Intra-and inter-assay coefficients France) and frozen at -80°C. The study was approved by the of variation (CV) observed in our laboratory were 5.8 and 8.6% University College London Hospitals Committee on the Ethics of respectively for the RPA 545 kit, and 4.7 and 13.5% respectively for Human Research.
the RPA 555 kit.
HPLC-radioimmunoassay Radioimmunoassay
Radioimmunoassay ET in plasma and fluids were extracted from Before HPLC purification, the adsorbed peptides from 2.5 ml fluid were eluted from Amprep columns with 2 ml of 80% acetonitrile supernatants using the Amersham (Les Ulis, France) Amprep C2 Ethyl (TM 500 mg columns). Immediately before the extraction 0.1% TFA. The mean recovery of ET during this extraction process was 79.8%. Chromatography separations were achieved on a reverse procedure, the samples were thawed and acidified with 4:1 (v:v) 2 mol/l HCl, then centrifuged at 10 000 g for 5 min at room phase Symmetry 300C18 (250ϫ4.6 mm, 5 µm) column (Waters, St Quentin en Yvelines, France), using an HPLC two pumps Waters temperature and loaded on to the column. The column was equilibrated by washing with 2 ml methanol followed by 2 ml water to which 510 system. Selection of the gradient was achieved with 1 nmol of each standard (ET-1, ET-2, ET-3) and then used for every was added 0.1% trifluoroacetic acid (TFA).
For radioimmunoassay, the adsorbed peptides were eluted with chromatography separation. Elution was performed at a flow rate of 0.7 ml/min with the following linear gradient: solvent A ϭ 0.1% 2 ml methanol 80% in water with 0.1% TFA. The mean recovery of ET during this extraction process was 58%. The eluted samples, TFA; solvent B ϭ 60% acetonitrile, 0.1% TFA. The gradient was A for 10 min, then B in A (v:v) from 0 to 50% for 10 min, from 50 to collected in polypropylene tubes, were evaporated and reconstituted in 250 µl assay buffer. Each 100 µl sample was assayed in duplicate.
65% for 30 min and to 100% for 5 min and then extensive washing. Data were collected and analysed in UV at 214 nm with a The mean recovery of ET-1 ( 125 I, 15 000 c.p.m.) during the extraction process was 57.5%. IrET was quantified using two different radiospectrophotometer (Waters 486) coupled with an integration software (Softron; Kontron, St Quentin en Yvelines, France) ( Figure 1 ). immunoassay kits: the ET-1, ET-2 (high sensitivity) [ 125 I] assay system (RPA 545), and the ET-1, ET-2 (high sensitivity) [ 125 I] Fractions (0.7 ml) were collected and evaporated to dryness. Determinations of ET concentration were performed using the ET-1, 21 assay system (RPA 555), both from Amersham (Les Ulis, France). With the RPA 545 kit, the antibody used reacted with the N-terminal
[125I] assay system RPA 555. The method has a lower limit of sensitivity of 0.5 pg/ml and the intra-and inter-assay CV were 4 and and incubated at 39°C for 60 min. In brief, 5 µl of the RT reaction product was subject to amplification in the presence of forward and reverse external oligonucleotide primers (0.4 µmol/l each), Table II (exon 2, nucleotides 97-118) and prepro-ET-2 lower (antisense) 5Ј-TGGCCTCCTGTTGTCGCTTGG-3Ј (exon 5, nucleotides 473-493) (Bloch et al., 1991) , the PCR conditions were 2 min at 92°C, 1 min at 62°C, 1 min at 72°C for 32 cycles. The primers used to amplify prepro-ET-3 were: prepro-ET-3 upper (sense) 5Ј-TCCTTTTCGGGC-TCACAG-3Ј (exon 1, nucleotides 130-147) (Onda et al., 1990 ) and prepro-ET-3 lower (antisense) 5Ј-TTGTGTGGGGAGATATGAC-3Ј (exon 3, nucleotides 589-608); the PCR conditions were 1 min at 94°C, 1 min at 59°C and 1 min at 72°C for 32 cycles. The PCR products were analysed by electrophoresis through a 3% Nusieve GTG agarose gel (FMC) and the DNA bands were visualized by ethidium bromide staining. The size of each DNA fragment was calculated using a reference DNA ladder (Life Technologies, Paris, France). Figure 2 . Reverse transcription-polymerase chain reaction Data were normally distributed and results were expressed as mean amplification of endothelins (ET) in placental villous tissue at 7 Ϯ SEM in pg/ml. Differences in means of irET concentrations in weeks of gestation showing a 442 bp for ET-1 (lane 1), 397 bp for ET-2 (lane 3) and 479 bp for ET-3 (lane 5) next to reference DNA matched series of samples were evaluated by the Student's paired ladders (lanes 2, 4 and 6). t-test. Linear regression equations were calculated by the least-square methods and their slopes tested for significance by the F ratio test. Results were considered statistically significant at P Ͻ 0.05. fluids, whereas the ET-3 concentration in the coelomic fluid was three times higher than that of amniotic fluid (Table II) .
Statistical analysis
No significant correlation was found between the concentra-
Results
tion of irET in coelomic or amniotic fluid samples and The irET concentrations, as evaluated by both the RPA 545 gestational age. Similar patterns of ET-1, ET-2 and ET-3 and the RPA 555 assays, were significantly higher in maternal concentrations were found in the coelomic and amniotic fluid. plasma than in coelomic or amniotic fluids (Table I) . Using After RT-PCR amplification, products of correct predicted the 545 kit assay, no difference was observed between the sizes, 442 bp for ET-1 (lane 1), 397 bp for ET-2 (lane 3) and coelomic and the amniotic fluid irET concentrations whereas 479 bp for ET-3 (lane 5) were each found in all three specimens when using the 555 kit assay the irET concentration in of placental tissue investigated (Figure 2 ). Southern blotting coelomic fluid was significantly higher than the amniotic fluid and hybridization with specific probes confirmed these results. concentration.
After HPLC, the three isoforms of ET were separated and Discussion recovered ( Figure 1) . By using the RPA 555 kit for further ET determination in fractions, ET-1 was found to be at a higher During the second half of uncomplicated pregnancies, irET concentrations are higher in umbilical plasma or amniotic fluid concentration in the coelomic fluid than in the amniotic fluid. No difference was found in the ET-2 contents of the two than in maternal plasma and increase in all three compartments with advancing gestation Iwata et al., 1991;  taining maternal blood acts as an endothelial layer (Robert et al., 1996) . Sagawa et al., 1994a,b) . The data of the present study indicate
The concentration of ET receptors is higher in first that between 7 and 12 weeks gestation irET concentrations trimester placenta and decreases progressively towards term are lower in fetal fluids compared to maternal plasma and (Kilpatrick et al., 1993) . Normal placentation is dependent on that these concentrations do not vary significantly during early trophoblast proliferation and infiltration, and because of that period. their vasoactive and mitogenic actions, ET may be involved The irET concentrations measured using both radioin placental growth and vascularization (Fant et al., 1992) . immunoassay kits were similar to those found in maternal As pregnancy advances, the simultaneous increase in the plasma between 8 and 12 weeks of gestation (Iwata et al., syncytiotrophoblastic surface and maternal blood volume 1991) and in samples of first trimester amniotic fluid (Sagawa entering the intervillous space can explain the gradual increase et al., 1994b) . Comparison with the data of other authors such in maternal ET concentration. In pre-eclampsia, there is a as those of Ihara et al. (1991) and Hakinen et al. (1992) is decreased release of ET-1 suggesting that ET may have a difficult because these authors have used different assays and possible role in the aetiology of this disease which is closely have not reported on the proportion of ET recovered during linked to a defect of placentation (Cervar et al., 1996) . the extraction process.
Mature ET peptides found in the coelomic fluid originate During the first 12 weeks of pregnancy, the embryo is probably from the endothelium of the villous capillaries and surrounded by two fluid cavities. The amniotic cavity in which the trophoblast as there is no anatomical barrier between the the embryo lies is bordered by the amniotic membrane which villous mesenchyme and the exocoelomic cavity. ET may also separates it from the exocoelomic or chorionic cavity (Jones be produced by the secondary yolk sac which is richly and Jauniaux, 1995) . The latter contains the secondary yolk vascularized and metabolically active between 5 and 10 weeks sac which is the first anatomical landmark inside the trophoof gestation (Jones and Jauniaux, 1995) . This finding and the blastic ring of the early gestational sac. Molecules crossing or slow turnover of the coelomic fluid (Jauniaux and Gulbis, produced by the villous trophoblast can either enter the fetal 1997) can explain the accumulation of ET-3 in the exococirculation directly via the villous capillaries or indirectly via elomic cavity. The similar proportions of ET-1, ET-2 and ETthe exocoelomic cavity and the secondary yolk sac (Jauniaux 3 found in coelomic and amniotic fluid samples indicates et Gulbis et al., 1998) . Higher irET concentrations the possible transfer of ET across the amniotic membrane were found in coelomic fluid using the 555 kit compared to separating these fluids. However, ET-1 and ET-2 are also that found with the 545 kit and in coelomic fluid compared produced by the amnion and the expression of prepro-ET-1 with that in amniotic fluid using the 555 kit, whereas conmRNA can be increased by growth factors, vasoactive agents centrations were similar in both fluids using the 545 kit. The and cytokines (Sunnergren et al., 1990; Mitchell et al., 1991) . antibody of the 555 kit cross-reacts with the three ET isoforms Amniotic irET concentrations are 5-fold higher at term than but not bigET-1, whereas that of the 545 kit cross-reacts with at 16-18 weeks gestation (Casey et al., 1992 ; Sagawa et al., ET-1, ET-2 and bigET-1 but not ET-3. This initially suggested 1994b; Carbonne et al., 1998) . However, the presence in the that the ET isoform pattern was different in these fluids due chorion laeve of a highly active enkephalinase which degrades to a higher concentration of ET-3 in the exocoelomic cavity ET (Casey and MacDonald, 1993) indicates that the ET compared with that in the amniotic cavity. The HPLC method produced by the amnion is of limited availability to the demonstrated that ET-3 was the predominant isoform in both myometrium and thus the role of amniotic ET in the initiation fluid compartments. Chromatography has been previously used of parturition remains controversial. These findings and the to measure the level of ET-like immunoreactivity in the human lower concentration of ET in amniotic than coelomic fluid fetus (Nisell et al., 1990; Hasegawa et al., 1991) . These authors suggest that, in early pregnancy, ET in both fluid cavities are found that ET-1 is the predominant isoform in amniotic mainly from placental villous origin. fluid samples collected during the second half of pregnancy, Recent experiments on the mouse (Baynash et al., 1994) suggesting that the ET isoform pattern may vary with advancing and the avian (Nataf et al., 1998) embryo have indicated that gestation.
ET-3, which we found to be the predominant isoform in both The placental tissue, which surrounds the whole gestational embryonic fluids, is essential for the development of the enteric sac during the first 2 months of gestation, is the main contributor neurons and melanocyte precursors. When the oropharyngeal to the coelomic fluid composition (Jauniaux and Gulbis, 1997) .
membrane opens during the second month of gestation, the The present data indicate that the first trimester placenta fetal pulmonary tract is exposed to amniotic fluid (Gulbis expresses all three ET precursor genes. At term, the human et al., 1996) . It has been suggested that amniotic ET contribute placenta expresses mainly ET-1 and ET-3, and ET have to the growth and maturation of the fetal lungs (Sagawa et al., been detected by in-situ immunocytochemistry in the villous 1994). As the lung and the gut both produce ET, the amniotic syncytiotrophoblast, the extravillous cytotrophoblast and the ET concentration measured in the present study is likely to endothelium of the fetal villous capillaries (Benigni et al., include ET production by these organs. In early pregnancy, 1991; Malassiné et al., 1993) . Trophoblastic cells in culture the fetal skin, which is not yet keratinized and thus highly continue to express the ET-1 and ET-3 precursor gene but not permeable, may also be a source of amniotic ET (Jauniaux the ET-2. These findings have suggested that the villous and Gulbis, 1997) . When the fetal metanephros starts producing urine from 10 weeks of gestation, the kidney probably becomes syncytiotrophoblast which lines the intervillous space con-program for selection of oligonucleotide primers for polymerase chain a major contributor to amniotic ET as for most amniotic fluid reactions. Nucleic Acid Res., 18, 1757 Res., 18, -1761 proteins (Gulbis et al., 1996) . The increasing fetal urinary Malassiné, A., Cronier, L., Mondon, F. et al. (1993) month of pregnancy and term (Carbonne et al., 1998) .
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